7410 related articles for article (PubMed ID: 12601018)
1. Expression of somatostatin receptors in uveal melanomas.
Ardjomand N; Ardjomand N; Schaffler G; Radner H; El-Shabrawi Y
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):980-7. PubMed ID: 12601018
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein expression in the eye and in uveal melanoma.
Missotten GS; Journée-de Korver JG; de Wolff-Rouendaal D; Keunen JE; Schlingemann RO; Jager MJ
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3059-65. PubMed ID: 12824252
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
[TBL] [Abstract][Full Text] [Related]
5. Expression of epidermal growth factor receptor: risk factor in uveal melanoma.
Hurks HM; Metzelaar-Blok JA; Barthen ER; Zwinderman AH; De Wolff-Rouendaal D; Keunen JE; Jager MJ
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2023-7. PubMed ID: 10892838
[TBL] [Abstract][Full Text] [Related]
6. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
[TBL] [Abstract][Full Text] [Related]
7. c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?
All-Ericsson C; Girnita L; Müller-Brunotte A; Brodin B; Seregard S; Ostman A; Larsson O
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2075-82. PubMed ID: 15223779
[TBL] [Abstract][Full Text] [Related]
8. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Vaijayanthi P; Krishnakumar S
Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
[TBL] [Abstract][Full Text] [Related]
9. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
[TBL] [Abstract][Full Text] [Related]
10. Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker.
Kouch-el Filali M; Kilic E; Melis M; de Klein A; de Jong M; Luyten GP
Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1585-92. PubMed ID: 18682975
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of pepsinogen C in uveal melanomas.
Alvarez ML; González LO; Barbón JJ; Astudillo A; Vizoso FJ
Int J Biol Markers; 2004; 19(3):240-4. PubMed ID: 15503827
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors.
Jha J; Singh MK; Singh L; Pushker N; Bajaj MS; Sen S; Kashyap S
Int J Clin Oncol; 2019 Dec; 24(12):1526-1535. PubMed ID: 31377937
[TBL] [Abstract][Full Text] [Related]
14. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptor scintigraphy in patients with metastatic uveal melanoma.
Valsecchi ME; Coronel M; Intenzo CM; Kim SM; Witkiewicz AK; Sato T
Melanoma Res; 2013 Feb; 23(1):33-9. PubMed ID: 23164993
[TBL] [Abstract][Full Text] [Related]
16. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma.
Seregard S; Oskarsson M; Spångberg B
Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1451-8. PubMed ID: 8641848
[TBL] [Abstract][Full Text] [Related]
17. Expression of neurotrophin receptors by retinoinvasive uveal melanoma.
Milman T; Hu DN; McCormick SA; Eagle RC; Crawford JB; Chin K; Shields CL; Shields JA; Char DH; Finger PT
Melanoma Res; 2012 Apr; 22(2):164-8. PubMed ID: 22343487
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
Ghazvini S; Kroll S; Char DH; Frigillana H
Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
[TBL] [Abstract][Full Text] [Related]
19. PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation postirradiation groups.
Pe'er J; Gnessin H; Shargal Y; Livni N
Ophthalmology; 1994 Jan; 101(1):56-62. PubMed ID: 7905616
[TBL] [Abstract][Full Text] [Related]
20. [HLA class I antigen expression correlates with histological cell type in uveal melanoma].
Dithmar S; Crowder J; Jager MJ; Vigniswaran N; Grossniklaus HE
Ophthalmologe; 2002 Aug; 99(8):625-8. PubMed ID: 12227276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
